Suven Life Sciences - Quaterly Results

08 Aug 2023 Evaluate
A fair growth of 7.29% in the revenue at Rs. 37.97 millions was reported in the June 2023 quarter as compared to Rs. 35.39 millions during year-ago period.The Net Loss for the quarter ended June 2023 is Rs. -28.71 millions as compared to Net Loss of Rs. -23.13 millions of corresponding quarter ended June 2022 Operating profit Margin for the quarter ended June 2023 further decreased to -11.55% as compared to -66.30% of corresponding quarter ended June 2022


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202306 202206 % Var 202306 202206 % Var 202303 202203 % Var
Sales 37.97 35.39 7.29 37.97 35.39 7.29 135.39 118.44 14.31
Other Income 56.40 4.36 1193.58 56.40 4.36 1193.58 84.49 16.01 427.73
PBIDT -11.55 -66.30 -82.58 -11.55 -66.30 -82.58 -192.95 -350.41 -44.94
Interest 0.51 1.02 -50.00 0.51 1.02 -50.00 2.89 5.30 -45.47
PBDT -12.06 -7.32 64.75 -12.06 -7.32 64.75 -135.84 -318.55 -57.36
Depreciation 16.65 15.81 5.31 16.65 15.81 5.31 65.43 43.93 48.94
PBT -28.71 -23.13 24.12 -28.71 -23.13 24.12 -201.27 -362.48 -44.47
TAX 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
PAT -28.71 -23.13 24.12 -28.71 -23.13 24.12 -201.27 -362.48 -44.47
Equity 218.07 145.38 50.00 218.07 145.38 50.00 218.07 145.38 50.00
PBIDTM(%) -30.42 -187.34 -83.76 -30.42 -187.34 -83.76 -142.51 -295.85 -51.83

Suven Life Sciences Share Price

136.90 1.65 (1.22%)
22-Jan-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1634.40
Dr. Reddys Lab 1217.15
Cipla 1371.55
Zydus Lifesciences 884.85
Lupin 2165.05
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×